Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016119
Filing Date
2022-08-09
Accepted
2022-08-09 16:32:43
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qtnt-20220630.htm   iXBRL 10-Q 2063680
2 EX-4.1 qtnt-ex4_1.htm EX-4.1 147201
3 EX-31.1 qtnt-ex31_1.htm EX-31.1 18291
4 EX-31.2 qtnt-ex31_2.htm EX-31.2 18249
5 EX-32.1 qtnt-ex32_1.htm EX-32.1 8561
6 EX-32.2 qtnt-ex32_2.htm EX-32.2 8683
  Complete submission text file 0000950170-22-016119.txt   8365626

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qtnt-20220630_def.xml EX-101.DEF 207397
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qtnt-20220630_pre.xml EX-101.PRE 351857
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qtnt-20220630_lab.xml EX-101.LAB 461833
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qtnt-20220630_cal.xml EX-101.CAL 57932
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qtnt-20220630.xsd EX-101.SCH 53832
63 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-20220630_htm.xml XML 1503347
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-36415 | Film No.: 221148867
SIC: 2835 In Vitro & In Vivo Diagnostic Substances